Concepedia

Publication | Closed Access

1188 GS-6620, A LIVER-TARGETED NUCLEOTIDE PRODRUG, EXHIBITS ANTIVIRAL ACTIVITY AND FAVORABLE SAFETY PROFILE OVER 5 DAYS IN TREATMENT NAIVE CHRONIC HCV GENOTYPE 1 SUBJECTS

DOI

11

Citations

0

References

2012

Year

E.J. Lawitz, Jacqueline Hill, T. Marbury, Lydie Hazan, Daniel Gruener, Lynn R. Webster, R. Majuskas, Rachel Morrison, M. DiMcco, Polina German,
Journal of Hepatology

No additional data available for this publication yet. Check back later!